US Stock MarketDetailed Quotes

PLX Protalix Biotherapeutics

Watchlist
  • 3.000
  • 0.0000.00%
Close May 2 16:00 ET
  • 3.000
  • 0.0000.00%
Post 20:01 ET
237.64MMarket Cap75.00P/E (TTM)

Protalix Biotherapeutics Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Total revenue
-18.47%53.4M
73.74%18.22M
73.60%17.96M
-61.59%13.47M
-60.91%3.75M
37.48%65.49M
21.69%10.49M
-27.06%10.35M
300.72%35.08M
-40.39%9.59M
Operating revenue
-18.47%53.4M
73.74%18.22M
73.60%17.96M
-61.59%13.47M
-60.91%3.75M
37.48%65.49M
21.69%10.49M
-27.06%10.35M
300.72%35.08M
-40.39%9.59M
Cost of revenue
5.82%24.32M
-56.12%3.89M
71.16%8.38M
53.81%9.46M
-15.66%2.6M
17.30%22.98M
269.46%8.86M
-30.83%4.89M
50.43%6.15M
-48.87%3.09M
Gross profit
-31.60%29.08M
779.26%14.33M
75.79%9.58M
-86.11%4.02M
-82.38%1.15M
51.58%42.51M
-73.79%1.63M
-23.31%5.45M
519.95%28.93M
-35.30%6.5M
Operating expense
-21.49%25.16M
-1.68%7.12M
-23.79%5.59M
-24.23%6.45M
-33.03%6M
-21.94%32.05M
-16.87%7.25M
-28.29%7.34M
-16.53%8.51M
-24.82%8.96M
Selling and administrative expenses
-18.49%12.19M
-27.61%3M
-29.29%2.6M
-13.57%3.48M
0.00%3.12M
27.73%14.96M
33.73%4.14M
28.86%3.67M
54.39%4.03M
-1.24%3.12M
Research and development costs
-24.12%12.97M
32.95%4.12M
-18.29%3M
-33.83%2.96M
-50.62%2.89M
-41.76%17.09M
-44.77%3.1M
-50.32%3.67M
-40.96%4.48M
-33.31%5.85M
Operating profit
-62.55%3.92M
228.39%7.21M
311.50%3.99M
-111.88%-2.43M
-97.48%-4.86M
180.37%10.46M
-125.05%-5.62M
39.62%-1.89M
469.68%20.42M
-31.50%-2.46M
Net non-operating interest income expense
112.51%237K
113.19%107K
-188.10%-148K
120.03%155K
125.79%123K
-36.95%-1.89M
-13.43%-811K
138.01%168K
-507.37%-774K
-14.66%-477K
Non-operating interest income
1.01%1.3M
405.41%113K
-75.96%151K
-1.69%522K
198.26%513K
12.22%1.29M
43.08%-37K
218.78%628K
-34.69%531K
-14.85%172K
Non-operating interest expense
-66.60%1.06M
-99.22%6K
-35.00%299K
-71.88%367K
-39.91%390K
25.74%3.18M
19.08%774K
-28.01%460K
109.47%1.31M
5.02%649K
Other net income (expense)
Income before tax
-51.51%4.15M
213.85%7.32M
323.56%3.84M
-111.56%-2.27M
-61.21%-4.73M
159.50%8.57M
-100.19%-6.43M
51.81%-1.72M
468.34%19.65M
-28.43%-2.94M
Income tax
381.10%1.22M
315.18%822K
356.39%607K
-122.40%-69K
-170.77%-138K
-52.08%254K
-172.08%-382K
133K
308K
195K
Net income
-64.73%2.93M
207.45%6.49M
274.73%3.24M
-111.39%-2.2M
-46.76%-4.6M
155.68%8.31M
-61.60%-6.04M
48.08%-1.85M
462.56%19.34M
-36.96%-3.13M
Net income continuous Operations
-64.73%2.93M
207.45%6.49M
274.73%3.24M
-111.39%-2.2M
-46.76%-4.6M
155.68%8.31M
-61.60%-6.04M
48.08%-1.85M
462.56%19.34M
-36.96%-3.13M
Minority interest income
Net income attributable to the parent company
-64.73%2.93M
207.45%6.49M
274.73%3.24M
-111.39%-2.2M
-46.76%-4.6M
155.68%8.31M
-61.60%-6.04M
48.08%-1.85M
462.56%19.34M
-36.96%-3.13M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-64.73%2.93M
207.45%6.49M
274.73%3.24M
-111.39%-2.2M
-46.76%-4.6M
155.68%8.31M
-61.60%-6.04M
48.08%-1.85M
462.56%19.34M
-36.96%-3.13M
Basic earnings per share
-66.67%0.04
190.00%0.09
233.33%0.04
-110.34%-0.03
-20.00%-0.06
138.71%0.12
-42.86%-0.1
57.14%-0.03
363.64%0.29
0.00%-0.05
Diluted earnings per share
-55.56%0.04
190.00%0.09
175.00%0.03
-114.29%-0.03
-20.00%-0.06
129.03%0.09
-42.86%-0.1
42.86%-0.04
290.91%0.21
0.00%-0.05
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Total revenue -18.47%53.4M73.74%18.22M73.60%17.96M-61.59%13.47M-60.91%3.75M37.48%65.49M21.69%10.49M-27.06%10.35M300.72%35.08M-40.39%9.59M
Operating revenue -18.47%53.4M73.74%18.22M73.60%17.96M-61.59%13.47M-60.91%3.75M37.48%65.49M21.69%10.49M-27.06%10.35M300.72%35.08M-40.39%9.59M
Cost of revenue 5.82%24.32M-56.12%3.89M71.16%8.38M53.81%9.46M-15.66%2.6M17.30%22.98M269.46%8.86M-30.83%4.89M50.43%6.15M-48.87%3.09M
Gross profit -31.60%29.08M779.26%14.33M75.79%9.58M-86.11%4.02M-82.38%1.15M51.58%42.51M-73.79%1.63M-23.31%5.45M519.95%28.93M-35.30%6.5M
Operating expense -21.49%25.16M-1.68%7.12M-23.79%5.59M-24.23%6.45M-33.03%6M-21.94%32.05M-16.87%7.25M-28.29%7.34M-16.53%8.51M-24.82%8.96M
Selling and administrative expenses -18.49%12.19M-27.61%3M-29.29%2.6M-13.57%3.48M0.00%3.12M27.73%14.96M33.73%4.14M28.86%3.67M54.39%4.03M-1.24%3.12M
Research and development costs -24.12%12.97M32.95%4.12M-18.29%3M-33.83%2.96M-50.62%2.89M-41.76%17.09M-44.77%3.1M-50.32%3.67M-40.96%4.48M-33.31%5.85M
Operating profit -62.55%3.92M228.39%7.21M311.50%3.99M-111.88%-2.43M-97.48%-4.86M180.37%10.46M-125.05%-5.62M39.62%-1.89M469.68%20.42M-31.50%-2.46M
Net non-operating interest income expense 112.51%237K113.19%107K-188.10%-148K120.03%155K125.79%123K-36.95%-1.89M-13.43%-811K138.01%168K-507.37%-774K-14.66%-477K
Non-operating interest income 1.01%1.3M405.41%113K-75.96%151K-1.69%522K198.26%513K12.22%1.29M43.08%-37K218.78%628K-34.69%531K-14.85%172K
Non-operating interest expense -66.60%1.06M-99.22%6K-35.00%299K-71.88%367K-39.91%390K25.74%3.18M19.08%774K-28.01%460K109.47%1.31M5.02%649K
Other net income (expense)
Income before tax -51.51%4.15M213.85%7.32M323.56%3.84M-111.56%-2.27M-61.21%-4.73M159.50%8.57M-100.19%-6.43M51.81%-1.72M468.34%19.65M-28.43%-2.94M
Income tax 381.10%1.22M315.18%822K356.39%607K-122.40%-69K-170.77%-138K-52.08%254K-172.08%-382K133K308K195K
Net income -64.73%2.93M207.45%6.49M274.73%3.24M-111.39%-2.2M-46.76%-4.6M155.68%8.31M-61.60%-6.04M48.08%-1.85M462.56%19.34M-36.96%-3.13M
Net income continuous Operations -64.73%2.93M207.45%6.49M274.73%3.24M-111.39%-2.2M-46.76%-4.6M155.68%8.31M-61.60%-6.04M48.08%-1.85M462.56%19.34M-36.96%-3.13M
Minority interest income
Net income attributable to the parent company -64.73%2.93M207.45%6.49M274.73%3.24M-111.39%-2.2M-46.76%-4.6M155.68%8.31M-61.60%-6.04M48.08%-1.85M462.56%19.34M-36.96%-3.13M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -64.73%2.93M207.45%6.49M274.73%3.24M-111.39%-2.2M-46.76%-4.6M155.68%8.31M-61.60%-6.04M48.08%-1.85M462.56%19.34M-36.96%-3.13M
Basic earnings per share -66.67%0.04190.00%0.09233.33%0.04-110.34%-0.03-20.00%-0.06138.71%0.12-42.86%-0.157.14%-0.03363.64%0.290.00%-0.05
Diluted earnings per share -55.56%0.04190.00%0.09175.00%0.03-114.29%-0.03-20.00%-0.06129.03%0.09-42.86%-0.142.86%-0.04290.91%0.210.00%-0.05
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------

Market Insights

U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks

Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data. Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data.

Unlock Now

Discussing

Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context, Show More

Reassessing Chinese Assets

Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.